Is your Immunoassay Out of Range? Strategies to Improve Dynamic Range and Assay Performance
Why Dynamic Range Matters More Than Ever in Immunoassay Development
In today's diagnostic landscape, assay developers are under increasing pressure to deliver tests that are not only highly sensitive, but also capable of accurately measuring analytes across a broad range of concentrations. Whether developing assays for infectious disease, cardiac biomarkers, oncology, or inflammatory markers, achieving robust performance across clinically relevant concentrations is critical.
Yet many immunoassays encounter a common challenge: limited dynamic range.
A narrow dynamic range can lead to sample dilution requirements, repeat testing, signal saturation, and reduced confidence in quantitative results. While developers often focus on antibody selection and detection chemistry, assay surfaces and reagent interactions can have an equally significant impact on assay performance.
At Surmodics IVD, we work with assay developers who are seeking to improve sensitivity, reduce background, and optimize overall assay robustness. One recurring theme is that dynamic range is often influenced by factors that extend well beyond the antibody pair itself.
Understanding Dynamic Range in Immunoassays
The dynamic range of an immunoassay refers to the span of analyte concentrations that can be measured accurately and reproducibly.
At the lower end of the range, assay performance is limited by background signal and analytical sensitivity. At the higher end, binding site saturation and signal compression can make it difficult to distinguish between high-concentration samples.
The broader the dynamic range, the greater the assay's ability to generate reliable quantitative results without additional sample preparation or repeat testing.
For clinical laboratories, this translates into greater efficiency. For assay developers, it can mean a more robust product and a smoother path to commercialization.
When Dynamic Range Becomes a Problem
Many assay developers recognize dynamic range limitations only after optimization efforts begin to stall. Common warning signs include:
Frequent Sample Dilutions
If high-concentration samples consistently require dilution, laboratory workflows become more complex and opportunities for error increase. Excessive dilution requirements may indicate that the assay's upper quantification limit is insufficient for the intended application.
Surmodics sample diluents can offer a one-step solution for dilution and sample normalization. Visit the link below for more information and/or reach out to our team today to request a free sample for evaluation.
Elevated Background Signal
Background noise can obscure low-level analyte detection and compromise assay sensitivity. As background increases, the usable lower end of the dynamic range shrinks.
Signal Saturation
A plateauing calibration curve often indicates that the assay has reached its maximum response capacity. Once saturation occurs, meaningful differences between samples can no longer be accurately measured.
Poor Assay Linearity
Compressed calibration curves or inconsistent recovery across concentrations may signal limitations in reagent performance, surface interactions, or assay architecture.
The Hidden Influence of Surface Chemistry
When developers encounter dynamic range challenges, troubleshooting efforts frequently focus on antibodies, assay formats, or detection systems. While these components are important, surface chemistry can be a foundational contributor to assay performance.
The assay surface serves as the platform where critical binding events occur. Its properties influence capture efficiency, biomolecule orientation, binding capacity, and resistance to nonspecific interactions.
Surface-related limitations can affect both ends of the dynamic range:
- Excess nonspecific binding can elevate background and reduce sensitivity.
- Poor biomolecule immobilization can limit analyte capture efficiency.
- Inconsistent surface performance can contribute to assay variability.
- Suboptimal binding capacity can restrict upper-range quantification.
Strategies for Expanding Dynamic Range
Improving dynamic range typically requires optimization across multiple assay components.
Minimize Nonspecific Binding
Reducing background signal is one of the most effective ways to improve low-end sensitivity. Surface chemistries designed to resist nonspecific interactions can help improve signal-to-noise ratios and extend assay performance at low analyte concentrations.
Visit the links below to learn more about Surmodics IVD’s reagents designed to tackle non-specific binding in immunoassays.
Protein Stabilizers, Diluents, & Blockers
Optimize Biomolecule Immobilization
Effective immobilization helps maximize the availability and functionality of capture molecules. Surfaces that support stable and reproducible attachment can contribute to improved assay sensitivity and consistency.
Evaluate Surface Performance Early
Surface selection is sometimes viewed as a downstream consideration. However, evaluating surface chemistry early in development can identify performance limitations before they become costly optimization challenges.
Balance Capture Density
While increasing capture reagent density may improve sensitivity, excessive loading can introduce steric hindrance and reduce binding efficiency. Achieving the optimal balance is essential for maximizing dynamic range.
Optimize Signal Generation
Detection systems, substrates, and assay conditions should be evaluated for both sensitivity and saturation behavior. Signal amplification strategies that preserve linearity across a broad concentration range can improve overall quantitative performance.
The BioFX™ TMB family has a broad range of kinetic rates with low background and improved signal‐to‐noise ratios that improve assay performance.
The one component 3,3’,5,5’-tetramethylbenzidine (TMB) substrate is supplied in a ready-to-use solution. Peroxidase reacts with the TMB substrate solution to produce a soluble blue reaction product that can be read at 370 nm or 620-650 nm for ELISA applications. Stop solutions can be added to prevent further color development and reading the absorbance values at the desired wavelengths.
Benefits of the BioFX™ family of substrates include:
- Prolonged stability
- Increased sensitivity
- Negligible backgrounds
- Ease of manufacturing
Building Assays for Real-World Clinical Samples
Patient samples rarely fall within a narrow concentration window. Biomarker levels can vary dramatically across patient populations, disease states, and stages of progression.
As a result, assays must be capable of performing reliably across a wide range of concentrations while maintaining accuracy and precision.
Developers who address dynamic range challenges early are often better positioned to reduce assay complexity, improve laboratory workflows, and enhance the clinical utility of their tests.
Surface Solutions That Support Assay Performance
At Surmodics IVD, we understand that assay performance begins at the surface.
Our portfolio of immunoassay reagents including our TRIDIA slides/coatings, stabilizers, diluents, substrates, and antigens/antibodies are designed to help assay developers address key performance challenges, including sensitivity, reproducibility, and background reduction.
By optimizing critical assay interfaces, developers can improve signal quality, reduce variability, and create immunoassays capable of delivering reliable results across broader concentration ranges.
The Bottom Line
Dynamic range is more than a technical specification—it is a critical determinant of immunoassay performance.
When assays fall outside their effective range, developers may face challenges including sample dilution requirements, elevated background, signal saturation, and reduced quantitative accuracy. Addressing these limitations requires a comprehensive approach that considers not only antibodies and detection systems, but also the surfaces and materials that support assay function.
As immunoassays continue to evolve toward greater sensitivity and broader clinical applications, optimizing dynamic range remains one of the most effective ways to improve assay performance and deliver better outcomes for laboratories and patients alike.
